Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Schweiger joined the Cleveland Clinic in 2010, as Associate Staff, Center for Pediatric and Adolescent Endocrinology. She has a special interest in Adolescent Female Health and Type 1 Diabetes and has co-authored several publications in both areas.
Dr. Schweiger is the manager of the ESCALAIT (enrichment services and care for adolescents living with autoimmune insulin dependent type 1 diabetes) Clinic. This is a multidisciplinary clinic with an aim of helping to enhance the care and well being of adolescent females with type 1 diabetes. She is also the manager of the Jr. ESCALAIT, a multidisciplinary clinic with the aim of providing support and improving the care of children with type 1 diabetes ages 5 and younger.
She is one of the principal investigators on the Cleveland Clinic Healthy Girls project with the goal of obesity prevention in at risk young females. Dr. Schweiger also heads the Pediatric Diabetes Ketoacidosis Task Force at Cleveland Clinic Children’s Hospital with the goal of continuing to enhance the inpatient care children with diabetes. She has been an invited speaker at local and international conference on various topics in adolescent medicine and type 1 diabetes. She is a member of the following organizations: The American Diabetes Association, The Endocrine Society, and The Pediatric Endocrine Society.
androgen disorders, growth disorders, pubertal disorders, thyroid disease, congenital hyperinsulinism, calcium disorders, panhypopituitarism, PCOS, type 1 diabetes, type 2 diabetes, MODY, neonatal diabetes
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Schweiger's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.